Maynard Um
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Amgen (AMGN)
-
-
-
-
-
-
-
BMO Capital Downgrades Amgen (AMGN) to Market Perform
-
-
-
-
-
-
-
Morgan Stanley tracks US drug market prescriptions for week ending July 31
-
-
-
-
-
-
-
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on Amgen (AMGN)
-
-
-
-
-
-
-
Amgen (AMGN) PT Lowered to $427 at Piper Sandler
-
-
-
-
-
-
-
Amgen (AMGN) call put ratio 1.5 calls to 1 put with a focus on May 365 calls into quarter results
-
467,161 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


